Angiogenic activity of human soluble intercellular adhesion molecule-1.

Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) are elevated in a number of pathological conditions associated with angiogenesis, including tumor growth. Because the increased levels of sICAM-1 suggested that it may be angiogenic, we tested the ability of sICAM-1 to promote angiogenesis. Human recombinant sICAM-1 stimulates chemokinetic endothelial cell migration, endothelial cell tube formation on Matrigel, and sprouting of aortic rings. sICAM-1 also mediates angiogenesis in the chick chorioallantoic membrane assay. Additionally, we found a Mr 49,000 molecule that binds to sICAM-1 that may be the surface ligand on endothelial cells. The evidence that sICAM-1 has angiogenic activity suggests a possible role linking inflammation and neovascularization. Furthermore, sICAM-1 may enhance tumor growth by promoting angiogenesis and escape from immunosurveillance.

[1]  H. Granger,et al.  Endothelial cell migration is induced by soluble P-selectin. , 1997, Life sciences.

[2]  Y. Gho,et al.  Anti-angiogenin Activity of the Peptides Complementary to the Receptor-binding Site of Angiogenin* , 1997, The Journal of Biological Chemistry.

[3]  M. Cohen,et al.  Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines. , 1996, Cancer letters.

[4]  H. Kleinman,et al.  Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. , 1995, Journal of cell science.

[5]  A. Koch,et al.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.

[6]  W. Brück,et al.  Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells , 1995, Journal of Neuroimmunology.

[7]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[8]  P. Bossù,et al.  Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. , 1993, Journal of immunology.

[9]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[10]  C. Scheibenbogen,et al.  Differential expression and release of LFA‐3 and ICAM‐1 in human melanoma cell lines , 1993, International journal of cancer.

[11]  S. J. Kim,et al.  Effect of cytokines on the expression of cell adhesion molecule and on the adhesion of melanoma cells to endothelial cells. , 1993, Journal of Korean medical science.

[12]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[13]  H. Kleinman,et al.  Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo , 1992, Journal of cellular physiology.

[14]  R. Giavazzi,et al.  Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice. , 1992, Cancer research.

[15]  J. Becker,et al.  Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. , 1991, Journal of immunology.

[16]  S. Bixler,et al.  Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1. , 1991, Journal of immunology.

[17]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[18]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[19]  M. Maio,et al.  Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. , 1997, British Journal of Cancer.

[20]  P. Polverini Role of the macrophage in angiogenesis-dependent diseases. , 1997, EXS.

[21]  H. Kleinman,et al.  Matrigel induces thymosin β 4 gene in differentiating endothelial cells , 1995 .